| Symbol | IVA |
|---|---|
| Name | INVENTIVA S.A. |
| Sector | HEALTH CARE |
| Region | Europe |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Address | 50 RUE DE DIJON, DAIX, 21121, France |
| Telephone | +33 380447500 |
| Fax | — |
| — | |
| Website | https://www.inventivapharma.com |
| Incorporation | UNDEFINED |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | — |
| Public Since | — |
| Exchanges | NASDAQ |
| Auditor | — |
| Audit Status | NOT PROVIDED |
| Reporting Status | — |
| CIK | 0001756594 |
| Description | Inventiva SA is a France-based biopharmaceutical company specialized in developing drugs that impact on nuclear receptors, transcription factors and epigenetic modulation. The company is focused on developing its product candidate, lanifibranor, for the treatment of patients with non-alcoholic steatohepatitis, or NASH, a disease for which there are currently no approved therapies. The company is also involved in developing a portfolio of pre-clinical therapy programs. It operates in the segment of Service delivery and clinical stage research, notably into therapies in the areas of oncology, fibrosis, and rare diseases. All the companys operations are in France. Additional info from NASDAQ: |
Correction: Inventiva Announces Preliminary Financial Results for the First Half of 2026¹
Read moreCorrection: Inventiva annonce ses résultats financiers préliminaires pour le premier semestre 2026¹
Read moreNew Form 6-K/A - Inventiva S.A. <b>Filed:</b> 2026-07-30 <b>AccNo:</b> 0001171843-26-005090 <b>Size:</b> 25 KB
Read moreInventiva annonce ses résultats financiers préliminaires pour le premier semestre 2026¹
Read moreInventiva Announces Preliminary Financial Results for the First Half of 2026¹
Read moreRésultats des Votes de l’Assemblée Générale Mixte des Actionnaires Réunie le 30 juin 2026
Read moreResults of the Votes of the Combined Shareholders’ General Meeting of June 30, 2026
Read moreInventiva annonce le Remboursement des Prêts BEI, le Rachat dune partie des BSA BEI etlémission des deux premières tranches dans le cadre du Nouveau Financement
Read moreInventiva announces Repayment of EIB Loans, Repurchase of a portion of EIB Warrants and the Issuance of the first two tranches under New Debt Financing
Read moreInventiva announces Repayment of EIB Loans, Repurchase of a portion of EIB Warrants and the Issuance of the first two tranches under New Debt Financing
Read more